
Bioinformatix provides a platform that helps health systems and payers reduce medication-related adverse events by continuously monitoring patient medication use across populations. It ingests and stores streams of clinical data from devices, providers, and claims, then applies AI and predictive analytics to detect risks and generate proactive alerts. The product is a B2B SaaS digital population health solution that integrates with EHRs and remote monitoring devices. Typical customers include hospitals, health systems, payers, and care management teams seeking medication intelligence and chronic care monitoring. The platform is designed for scalable deployment across settings from in-hospital care to home monitoring.

Bioinformatix provides a platform that helps health systems and payers reduce medication-related adverse events by continuously monitoring patient medication use across populations. It ingests and stores streams of clinical data from devices, providers, and claims, then applies AI and predictive analytics to detect risks and generate proactive alerts. The product is a B2B SaaS digital population health solution that integrates with EHRs and remote monitoring devices. Typical customers include hospitals, health systems, payers, and care management teams seeking medication intelligence and chronic care monitoring. The platform is designed for scalable deployment across settings from in-hospital care to home monitoring.
Founded: 2016
Headquarters: Boston, Massachusetts, United States
Product: Rx&You — medication-intelligence population health SaaS
Primary customers: Hospitals, health systems, payers, care management teams
Known investor: Startupbootcamp Digital Health Chengdu (seed)
Medication safety, population health monitoring, chronic care management
2016
Biotechnology
Seed round announced June 21, 2017; amount not disclosed in available evidence.